FACTORS AFFECTING LDL-C CONTROL IN PATIENTS WITH CHRONIC CORONARY SYNDROME AT THAI BINH GENERAL HOSPITAL
Main Article Content
Abstract
Objective: To determine the proportion of patients achieving LDL-C targets and analyze the factors influencing LDL-C control in patients with chronic coronary syndrome at Thai Binh General Hospital. Methods: A cross-sectional descriptive study was conducted on 198 patients diagnosed with chronic coronary syndrome. Data were collected from medical records, LDL-C test results, and patient interviews. Statistical analysis was performed using SPSS 26.0, employing Chi-square tests, t-tests, and multivariate logistic regression to identify factors related to LDL-C control. Results: 31.8% of patients achieved the LDL-C target (<1.8 mmol/L), while 68.2% did not. Key influencing factors: Good treatment adherence significantly increased the likelihood of achieving LDL-C targets (26.8% vs. 0%, p = 0.001). Physical activity and a healthy diet had significant impacts (p < 0.01). Smoking reduced the ability to control LDL-C (p = 0.03). Conclusion: The proportion of patients achieving LDL-C targets remains low. Optimizing statin therapy, enhancing patient education on medication adherence, and promoting a healthy lifestyle are essential for better lipid control.
Article Details
Keywords
LDL-C, chronic coronary syndrome, lipid control, risk factors, treatment adherence, lifestyle
References

2. Mach, F., Baigent, C., Catapano, A. L., Koskinas, K. C, et. al. (2023), "ESC Guidelines on cardiovascular disease prevention in clinical practice", European Heart Journal. 44(24), 1543-1636.

3. Ference, B. A., Graham, I., Tokgozoglu, L., & Catapano, A. L. (2019), "Impact of lipids on cardiovascular health: JACC Health Promotion Series.", Journal of the American College of Cardiology. 72(10), 1141-1156.

4. Nguyễn Thị Hoài An, Nguyễn Lân Việt và Tuấn., Nguyễn Quang (2021), "Thực trạng kiểm soát lipid máu ở bệnh nhân bệnh tim mạch do xơ vữa động mạch tại Bệnh viện Bạch Mai", Tạp chí Tim mạch học Việt Nam. 102, 35-42.

5. De Bacquer, D., Astin, F., Kotseva, K., et al (2020), "Poor adherence to lifestyle recommendations in patients with coronary heart disease: results from the EUROASPIRE surveys.", European Journal of Preventive Cardiology,. 29(2), 152-161.

6. Zhao, M., Cooney, M. T., Klipstein-Grobusch, K (2022), "Simplifying the audit of risk factor control: A comparison of the care gap in patients with coronary heart disease across Europe", European Journal of Preventive Cardiology,. 29(2), 179-189.

7. Ference, B. A., Ginsberg, H. N., Graham, I (2017), "Low-density lipoproteins cause atherosclerotic cardiovascular disease: 1. Evidence from genetic, epidemiologic, and clinical studies.", European Heart Journal. 38(32), 2459-2472.

8. Rodriguez, F., Maron, D. J., Knowles, et al (2020), "Association of statin adherence with mortality in patients with atherosclerotic cardiovascular disease. ", JAMA Cardiology. 4(3), 206-213.

9. Boekholdt, S. M., Hovingh, G. K., Waters, D. D., et al. (2014), "Very low levels of atherogenic lipoproteins and the risk for cardiovascular events: a meta-analysis of statin trials.", ournal of the American College of Cardiology. 64(5), 485-494.

10. Kim, S. J., Kwon, O. D., Kim, K. S., et al. (2021), "Prevalence, awareness, treatment, and control of dyslipidemia among diabetes mellitus patients and predictors of optimal dyslipidemia control: results from the Korea National Health and Nutrition Examination Survey", Lipids in Health and Disease. 20(1), 102-113.

